CN105106916A - 一种产后护理用中药 - Google Patents
一种产后护理用中药 Download PDFInfo
- Publication number
- CN105106916A CN105106916A CN201510628992.7A CN201510628992A CN105106916A CN 105106916 A CN105106916 A CN 105106916A CN 201510628992 A CN201510628992 A CN 201510628992A CN 105106916 A CN105106916 A CN 105106916A
- Authority
- CN
- China
- Prior art keywords
- chinese medicine
- fructus
- traditional chinese
- radix
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 38
- 230000000474 nursing effect Effects 0.000 title abstract 6
- 210000000582 semen Anatomy 0.000 claims abstract description 26
- 241000628997 Flos Species 0.000 claims description 24
- 239000000843 powder Substances 0.000 claims description 11
- 241000756943 Codonopsis Species 0.000 claims description 8
- 241001506047 Tremella Species 0.000 claims description 8
- 239000006187 pill Substances 0.000 claims description 7
- 230000000694 effects Effects 0.000 abstract description 18
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 239000002994 raw material Substances 0.000 abstract description 7
- 208000024891 symptom Diseases 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 244000223014 Syzygium aromaticum Species 0.000 abstract 2
- 235000016639 Syzygium aromaticum Nutrition 0.000 abstract 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000132012 Atractylodes Species 0.000 abstract 1
- 244000045232 Canavalia ensiformis Species 0.000 abstract 1
- 235000010520 Canavalia ensiformis Nutrition 0.000 abstract 1
- 235000010518 Canavalia gladiata Nutrition 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 abstract 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 abstract 1
- 235000009685 Crataegus X maligna Nutrition 0.000 abstract 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 abstract 1
- 235000009486 Crataegus bullatus Nutrition 0.000 abstract 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 abstract 1
- 235000009682 Crataegus limnophila Nutrition 0.000 abstract 1
- 235000004423 Crataegus monogyna Nutrition 0.000 abstract 1
- 240000000171 Crataegus monogyna Species 0.000 abstract 1
- 235000002313 Crataegus paludosa Nutrition 0.000 abstract 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 abstract 1
- 244000000626 Daucus carota Species 0.000 abstract 1
- 240000005979 Hordeum vulgare Species 0.000 abstract 1
- 235000007340 Hordeum vulgare Nutrition 0.000 abstract 1
- 244000025221 Humulus lupulus Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000908178 Tremella fuciformis Species 0.000 abstract 1
- 244000273928 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 238000010521 absorption reaction Methods 0.000 abstract 1
- 235000005770 birds nest Nutrition 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- 235000005765 wild carrot Nutrition 0.000 abstract 1
- 210000000952 spleen Anatomy 0.000 description 31
- 239000008280 blood Substances 0.000 description 26
- 210000004369 blood Anatomy 0.000 description 25
- 210000002784 stomach Anatomy 0.000 description 21
- 210000003734 kidney Anatomy 0.000 description 18
- 235000009508 confectionery Nutrition 0.000 description 17
- 230000007812 deficiency Effects 0.000 description 16
- 210000004072 lung Anatomy 0.000 description 16
- 210000004185 liver Anatomy 0.000 description 13
- 230000001276 controlling effect Effects 0.000 description 11
- 206010011224 Cough Diseases 0.000 description 10
- 208000002193 Pain Diseases 0.000 description 10
- 230000036407 pain Effects 0.000 description 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 206010047700 Vomiting Diseases 0.000 description 8
- 201000010099 disease Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 7
- 230000008673 vomiting Effects 0.000 description 7
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 201000006549 dyspepsia Diseases 0.000 description 6
- 229930003944 flavone Natural products 0.000 description 6
- 235000011949 flavones Nutrition 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 238000010792 warming Methods 0.000 description 6
- 239000002253 acid Substances 0.000 description 5
- 210000001124 body fluid Anatomy 0.000 description 5
- 239000010839 body fluid Substances 0.000 description 5
- 230000002950 deficient Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 239000000341 volatile oil Substances 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 4
- 230000002411 adverse Effects 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- -1 flavone compound Chemical class 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000003014 reinforcing effect Effects 0.000 description 4
- 230000002936 tranquilizing effect Effects 0.000 description 4
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 208000000059 Dyspnea Diseases 0.000 description 3
- 206010013975 Dyspnoeas Diseases 0.000 description 3
- 208000031361 Hiccup Diseases 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- CHNUNORXWHYHNE-UHFFFAOYSA-N Oxadiazon Chemical compound C1=C(Cl)C(OC(C)C)=CC(N2C(OC(=N2)C(C)(C)C)=O)=C1Cl CHNUNORXWHYHNE-UHFFFAOYSA-N 0.000 description 3
- 239000005588 Oxadiazon Substances 0.000 description 3
- 208000029785 Puerperal disease Diseases 0.000 description 3
- 206010037294 Puerperal pyrexia Diseases 0.000 description 3
- 208000025747 Rheumatic disease Diseases 0.000 description 3
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 3
- 208000019790 abdominal distention Diseases 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 208000017574 dry cough Diseases 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 210000001624 hip Anatomy 0.000 description 3
- 229910052739 hydrogen Inorganic materials 0.000 description 3
- 239000001257 hydrogen Substances 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 206010022437 insomnia Diseases 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000000552 rheumatic effect Effects 0.000 description 3
- 239000000932 sedative agent Substances 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- RIXNFYQZWDGQAE-DFHVBEEKSA-N (4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-acetyloxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydropicene-4a-carboxylic acid Chemical compound C([C@H]1C2=CC[C@H]34)C(C)(C)CC[C@]1(C(O)=O)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](OC(=O)C)C1(C)C RIXNFYQZWDGQAE-DFHVBEEKSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010022998 Irritability Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 208000007107 Stomach Ulcer Diseases 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000036592 analgesia Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 239000003866 digestant Substances 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000000718 duodenal ulcer Diseases 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 206010013990 dysuria Diseases 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- QOLIPNRNLBQTAU-UHFFFAOYSA-N flavan Chemical compound C1CC2=CC=CC=C2OC1C1=CC=CC=C1 QOLIPNRNLBQTAU-UHFFFAOYSA-N 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 150000002213 flavones Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 244000053095 fungal pathogen Species 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 239000000413 hydrolysate Substances 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 238000002649 immunization Methods 0.000 description 2
- 230000003053 immunization Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 230000001568 sexual effect Effects 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LAOOXBLMIJHMFO-UHFFFAOYSA-N 1-[2-(diethylamino)ethylamino]-4-methylthioxanthen-9-one;hydron;chloride Chemical compound Cl.S1C2=CC=CC=C2C(=O)C2=C1C(C)=CC=C2NCCN(CC)CC LAOOXBLMIJHMFO-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- QRDZSRWEULKVNW-UHFFFAOYSA-N 6-hydroxy-2-oxo-1h-quinoline-4-carboxylic acid Chemical compound C1=C(O)C=C2C(C(=O)O)=CC(=O)NC2=C1 QRDZSRWEULKVNW-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000193738 Bacillus anthracis Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 201000009030 Carcinoma Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010726 Conjunctival oedema Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010017999 Gastrointestinal pain Diseases 0.000 description 1
- 206010018275 Gingival atrophy Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000012659 Joint disease Diseases 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000029578 Muscle disease Diseases 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 241000522620 Scorpio Species 0.000 description 1
- JVXZRQGOGOXCEC-UHFFFAOYSA-N Scutellarein Natural products C1=CC(O)=CC=C1C1=CC(=O)C2=C(O)C(O)=C(O)C=C2O1 JVXZRQGOGOXCEC-UHFFFAOYSA-N 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 1
- 229960004373 acetylcholine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000003260 anti-sepsis Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 239000003907 antipyretic analgesic agent Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 201000009361 ascariasis Diseases 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000035614 depigmentation Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 201000005562 gingival recession Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 230000002984 haematinic effect Effects 0.000 description 1
- 229940043316 hawthorn preparation Drugs 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000001077 hypotensive effect Effects 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- LWYXLXAMDLNBFQ-UHFFFAOYSA-N iso-6-Carnavalin Natural products CC(O)CCCCCCCCCCC1CCC(O)C(C)N1 LWYXLXAMDLNBFQ-UHFFFAOYSA-N 0.000 description 1
- 210000001630 jejunum Anatomy 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 208000025036 lymphosarcoma Diseases 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000000865 mononuclear phagocyte system Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 210000004279 orbit Anatomy 0.000 description 1
- 201000005737 orchitis Diseases 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000001843 schistosomicidal effect Effects 0.000 description 1
- 239000009490 scorpio Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000012232 skeletal muscle contraction Effects 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及中药应用领域,特别公开了一种产后护理用中药。该产后护理中药由蕤仁,酸枣仁,广枣,干姜,丁香,母丁香,刀豆,山楂,啤酒花,稻芽,薏米仁,藏菖蒲,党参,白术,枸杞子,山药,太子参,当归,女贞子,天冬,燕窝和银耳为原料,按照一定的重量配比混合配制而成。本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
Description
(一)技术领域
本发明涉及中药应用领域,特别涉及一种产后护理用中药。
(二)背景技术
产后病,也称月子病,月子病是指妇女在生产(包括小产)之后一个月内所受到的外感或内伤而引起的疾患,在月子里没有治愈而留下的病症。妇女在生产后,因筋骨腠理大开,身体虚弱,内外空疏,如果此时不慎使风寒侵入,或大怒大悲,或过多房事,都能引起月子病。临床表现:主要症状有全身肌肉关节麻木、疼痛、酸胀、怕风、怕冷、不耐劳累、屈伸不利为主要表现,严重者每当感受凉风之时就有凉风钻到骨头里的感觉,患者即使在暑热时节其患处也必须裹以厚被或棉衣才能感觉舒适。其症状特征是出凉汗、遇风、遇冷后症状加重,但受累关节和肌肉无红肿等典型的炎症表现。其他表现型尚有身体困乏、心烦急躁,失眠多梦等、部分患者尚有头痛、头晕、眼眶疼痛、眼睛干涩或多泪、视物模糊、体弱多病等征候。产后风湿看上去很象风湿病,但患病关节、肌肉无红肿,血沉、抗链球菌“O”以及产后风湿因子等常见的风湿病化验指标多正常,按常规抗风湿也无效果。此时如果治疗不及时或治疗不当,病邪长期滞留于体内,就会逐渐侵蚀腠理与筋骨经络组织,导致严重的筋骨病或形成难治脏腑病症。病因:一是亡津失血,由于分娩用力、出汗和产伤或失血过多,使阴血骤虚,加之产后调养不慎,以致亡津失血,阳气浮散。二是瘀血内阻,产后元气亏虚,气血无力,气滞血虚;或产后百脉空虚,易感外邪,寒邪乘虚入体,血为寒凝,以导致恶露不畅,留而成瘀;或复因产前即有气郁血滞,以致瘀血内阻;或因产后余血浊液生瘀滞,或胞衣残留或感染邪毒,均可导致瘀血内阻,败血为患。三是外感六淫或饮食房劳所伤,产后气血俱伤,元气受损,正气减弱,即所谓“产后百脉空虚”,因身体虚弱,稍有感触,或产时、产后调理不慎,均可导致脏腑功能失常,变生百病。总之,产后病以“虚”、“瘀”为主,故有“产后多虚多瘀”之说。
(三)发明内容
本发明为了弥补现有技术的不足,提供了一种制备简单、疗效显著的产后护理中药。
本发明是通过如下技术方案实现的:
一种产后护理用中药,由以下重量份数的中药制成:
蕤仁6~15g,酸枣仁6~15g,广枣7~15g,干姜6~15g,丁香3~6g,母丁香6~12g,刀豆6~15g,山楂10~15g,啤酒花6~8g,稻芽6~9g,薏米仁10~15g,藏菖蒲3~6g,党参6~9g,白术6~12g,枸杞子10~16g,山药15~26g,太子参12~26g,当归15~25g,女贞子10~26g,天冬10~20g,燕窝10~20g,银耳3~6g。
其优选的各原料的重量配比为:
蕤仁6g,酸枣仁6g,广枣7g,干姜6g,丁香3g,母丁香6g,刀豆6g,山楂10g,啤酒花6g,稻芽6g,薏米仁10g,藏菖蒲3g,党参6g,白术6g,枸杞子10g,山药15g,太子参12g,当归15g,女贞子10g,天冬10g,燕窝10g,银耳3g。
本发明所述中药为散剂或丸剂,将各种原料清洗干净后,打粉混合,制成散剂或丸剂定量服用。
其中各原料的药用性能为:
蕤仁:性微寒,味甘。归肝经。养肝明目、疏风散热。属安神药下属分类的养心安神药。用治目赤肿痛、睑弦赤烂、目暗羞明。
酸枣仁:性平,味甘、酸。归肝经、胆经、心经。补肝、宁心、敛汗、生津。属安神药下属分类的养心安神药。用治虚烦不眠、惊悸多梦、体虚多汗、津伤口渴。具有镇静催眠、镇静降温、抗惊厥、降压、抗心功能。
广枣:性平,味甘、酸。行气活血、养心、安神。属安神药下分类的养心安神药。治气滞血瘀、胸痹作痛、心悸气短、心神不安。
干姜:性热,味辛。归脾经、胃经、心经、肾经、肺经。温中散寒、回阳通脉、燥湿消痰。治脘腹冷痛、肢冷脉微、痰饮喘咳、胃肠气痛和绞痛、风湿痛、腰腿痛、胃及十二指肠溃疡、急性菌痢、急性睾丸炎、蛔虫病肠梗阻、慢性消化不良。水煎液及浸膏有中枢兴奋、健胃、止呕、抗菌作用;挥发油有抗炎及解热止痛作用。具有镇静、镇痛、抗炎、升血压、抗凝血作用;对消化系统具有止吐、增强离体肠收缩等作用;灭螺,抗血吸虫,促进肾上腺皮质激素的合成与释放。
丁香:味辛,性温。归胃经、脾经、肾经。治脾胃虚寒、呃逆呕吐、食少吐泻、心腹冷痛、肾虚阳痿。温中降逆、补肾助阳。具健胃作用,浸出液具有明显的刺激胃液分泌作用,并能缓解腹胀、恶心、呕吐等。另外,对多种致病性真菌、球菌、链球菌及肺炎、痢疾、大肠、伤寒等杆菌以及流感病毒有抑制作用。
母丁香:味辛,性温。归脾经、胃经、肺经、肾经。温中降逆、散寒止痛。温中降逆、散寒止痛。属温里药。治脾胃虚寒,呃逆呕吐,食少吐泻,心腹冷痛,牙宣,口臭,妇人阴冷,小儿疝气。
刀豆:性温,味甘。归胃经、肾经。温中、下气、止呕。属温里药。治脾胃虚寒所致呃逆、呕吐、肾虚腰腿酸痛无力等。含刀豆球蛋白,是植物凝血素,具有强力促有丝分裂作用,能较好地促淋巴细胞转化反应,选择性激活抑制性T细胞;刀豆毒素还有脂氧酶激活作用。
山楂:性微温,味酸、甘。归脾经、胃经、肝经。消食健脾、行气消瘀。治疗肉食积滞、小儿乳积、脘腹胀痛、痢疾、泄泻、痛经、产后瘀血腹痛、高血脂症等。主要含有机酸(柠檬酸及其甲酯、苹果酸等)及黄酮类化合物(金丝桃苷、槲皮素、牡荆素等)。山楂中有机酸是消食导滞的有效成分,黄酮类化合物是防治心血管病及降血脂的活性成分。德国将山楂制剂作为治疗心血管疾病的药物,已载人药典,缩合黄烷(黄烷聚合物)是其质量标准之一。山楂黄酮或水解物对离体或在体蟾蜍心脏均有强心作用;浸膏、黄酮或水解物能增加冠脉流量;总黄酮、水解物、三萜酸具降压作用;提取物、醇浸膏、总三萜酸提取物能降血脂;此外,具增强免疫、抗氧化、抗菌作用。毒性:总黄酮小鼠腹腔注射LDso为165毫克/千克。
啤酒花:性微凉,味苦;无毒。归肝经、胃经。健胃消食、利尿安神。属消食药。治疗消化不良、腹胀、浮肿、膀胱炎、肺结核、失眠,含氢草二烯酮、氢草酮、蛇麻酮、鞣质、挥发油等。浸膏、蛇麻酮、氢草酮试管内能抑制多种革兰氏阳性细菌的生长,对致病性、非致病性真菌及放线菌抑制效力极弱;蛇麻酮、氢草酮具有镇静作用;树脂中的β-酸具有较强的雌性激素样作用;酿造啤酒时加入本品,不仅由于其挥发油具有香味,而且有防腐作用;乙醇提取物对离体兔空肠、豚鼠十二指肠、大鼠子宫平滑肌有强大的解痉作用,并能拮抗乙酰胆碱、氯化钡的致痉作用。
稻芽:性温,味甘。归脾、胃经。和中消食、健脾开胃。属消食药。治米面薯芋等淀粉类食物所致的食滞、脘腹胀满,或脾虚食少等。
薏米仁:性凉,味甘、淡。归脾经、胃经、肺经。健脾利湿、除痹止泻、清热排脓。用治水湿停蓄之水肿、小便不利、淋浊、脚气浮肿、脾虚泄泻、湿痹筋脉拘挛、屈伸不利或痿弱无力、肺痈、咳吐脓痰、肠痈等。本品有抑制骨骼肌收缩、解热、镇痛、抗炎、抗肿瘤和增强免疫功能等作用;还能轻度降低血糖。藏菖蒲:性温,味苦、辛。温胃,消炎止痛。补胃阳、消化不良、食物积滞、白喉、炭疽等。配全蝎、白附子、皂角炭、制南星和远志等研末,制成蜜丸服用,治疗癫痫。具有安神镇静、抗惊厥和降温等作用。
党参:性平,味甘。归脾经、肺经。补中益气、健脾益肺。属补虚药下属分类的补气药。用治脾肺虚弱、气短心悸、食少便溏、虚喘咳嗽、内热消渴,含挥发油、黄芩素葡萄糖苷、微量生物碱、多糖及皂苷。水煎液灌胃,使小鼠对钴一γ射线有一定保护作用。多糖对实验动物应激性溃疡等多种溃疡均有明显的对抗作用。水、醇提物有中枢镇静作用,能改善小鼠的记忆过程和加强造血功能,并有抗血栓和调血脂的作用。
白术:性温,味甘、苦。归脾经、胃经。健脾、益气、燥湿利水、止汗、安胎。属补虚药下属分类的补气药。用治脾胃气弱、不思饮食、倦怠少气、虚胀、泄泻、痰饮、水肿、黄疸、湿痹、小便不利、头晕、自汗、胎气不安等。主要含有挥发油,挥发油中的主要成分为苍术酮。白术中还分离得一种多糖——甘露聚糖AM-3,有免疫增强作用。可应用薄层扫描法测定白术中苍术酮的含量。有明显且持久的抗利尿作用,对小鼠艾氏腹水癌、淋巴肉瘤腹水瘤及人109食管癌都有显著的抑制作用;对胃肠系统有双向调节作用,能抗胃溃疡;此外,还有解痉、保肝、抗菌等药理作用。
枸杞子:性平,味甘。归肝经、肾经。滋补肝肾、益精明目。属补虚药下属分类的补气药。用治虚劳精亏、腰膝酸痛、眩晕耳鸣、内热消渴、血虚萎黄、目昏不明。含多糖、脂肪酸、甜菜碱、胡萝卜素、核黄素、烟酸、氨基酸、维生素C及多种微量元素等。具有抗脂肪肝、抗衰老、提高免疫力等作用。
山药:性平,味甘。归脾经、肺经、肾经。补脾养胃、生津益肺、补肾涩精。属补虚药下属分类的补气药。用治脾虚食少、久泻不止、肺虚喘咳、肾虚遗精、带下、尿频、虚热消渴等。麸炒山药补脾健胃,用治脾虚食少、泄泻便溏、白带过多。
太子参:性平,味甘、微苦。归脾经、肺经。益气健脾、生津润肺。属补虚药下属分类的补气药。用治脾虚体倦、食欲不振、病后虚弱、气阴不足、自汗口渴、肺燥干咳。
当归:性温,味甘、辛。归肝经、心经、脾经。补血活血、调经止痛、润肠通便。属补虚药下属分类的补血药。用治血虚萎黄、眩晕心悸、月经不调、经闭痛经、虚寒腹痛、肠燥便秘、风湿痹痛、跌扑损伤、痈疽疮疡。
女贞子:性凉,味甘、苦。归肝经、肾经,滋补肝肾、明目乌发。用治肝肾阴虚而致耳鸣、耳聋、头晕、腰膝酸软、须发早白等。主要活性成分为三萜类化合物,主要有齐墩果酸、乙酰齐墩果酸等。本品有升高外周白细胞、增强网状内皮系统吞噬能力、增强细胞免疫和体液免疫的作用;对化疗或放疗所致的白细胞减少有升高作用;有强心、利尿及保肝作用;并有止咳、缓泻、抗菌、抗癌等作用。
天冬:性寒,味甘、苦。归肺经、肾经。养阴润燥、润肺生津。属补虚药下属分类的补阴药。用治肺热干咳、顿咳痰黏、咽干口渴、肠燥便秘。
燕窝:味甘、性平,入肺、脾、肾经;可养阴润燥、益气补中;清虚热,治虚损,并且对咯血吐血、久咳痰喘,阴虚发热等导致津液脱失的病症有良好效果。
银耳:性平,味甘、淡、无毒。具有强精、补肾、润肠、益胃、补气、和血、强心、壮身、补脑、提神、美容、嫩肤、延年益寿之功效。用于治肺热咳嗽、肺燥干咳、妇女月经不调、胃炎、大便秘结等病症。
临床观察:
(1)临床资料
本发明人于2009年至今,对274例产后病患者进行临床观察治疗。
(2)治疗方法
口服,一日三次,每次2~5g,饭后服用。根据患者病情轻重计算治疗时间,轻度患者服用10~15天治愈,重病患者连服20~60治愈。
(3)临床结果:
临床治愈215例(78.47%),显效39例(14.23%),有效17例(6.21%),无效3例(1.09%),总有效率为98.91%。
本发明配制简单,吸收效果好,药效持续时间长,疗效显著,无副作用,安全性高,生产成本低,有利于病患及时减轻病状。
(四)具体实施方式
实施例1:
取蕤仁6g,酸枣仁6g,广枣7g,干姜6g,丁香3g,母丁香6g,刀豆6g,山楂10g,啤酒花6g,稻芽6g,薏米仁10g,藏菖蒲3g,党参6g,白术6g,枸杞子10g,山药15g,太子参12g,当归15g,女贞子10g,天冬10g,燕窝10g,银耳3g,将上述原料清洗干净,打粉混合,制成散剂或丸剂。
用法用量:口服,一日三次,每次2~5g,饭后服用。
实施例2:
取蕤仁15g,酸枣仁15g,广枣15g,干姜15g,丁香6g,母丁香12g,刀豆15g,山楂15g,啤酒花8g,稻芽9g,薏米仁15g,藏菖蒲6g,党参9g,白术12g,枸杞子16g,山药26g,太子参26g,当归25g,女贞子26g,天冬20g,燕窝20g,银耳6g,将上述原料清洗干净,打粉混合,制成散剂或丸剂。
用法用量:口服,一日三次,每次2~5g,饭后服用。
实施例3:
取蕤仁12g,酸枣仁12g,广枣12g,干姜12g,丁香4g,母丁香10g,刀豆12g,山楂12g,啤酒花7g,稻芽7g,薏米仁12g,藏菖蒲5g,党参7g,白术10g,枸杞子12g,山药19g,太子参18g,当归20g,女贞子12g,天冬15g,燕窝15g,银耳5g,将上述原料清洗干净,打粉混合,制成散剂或丸剂。
用法用量:口服,一日三次,每次2~5g,饭后服用。
Claims (3)
1.一种产后护理用中药,其特征为,由以下重量份数的中药制成:蕤仁6~15g,酸枣仁6~15g,广枣7~15g,干姜6~15g,丁香3~6g,母丁香6~12g,刀豆6~15g,山楂10~15g,啤酒花6~8g,稻芽6~9g,薏米仁10~15g,藏菖蒲3~6g,党参6~9g,白术6~12g,枸杞子10~16g,山药15~26g,太子参12~26g,当归15~25g,女贞子10~26g,天冬10~20g,燕窝10~20g,银耳3~6g。
2.根据权利要求1所述的一种产后护理用中药,其特征为,由以下重量份数的中药制成:蕤仁6g,酸枣仁6g,广枣7g,干姜6g,丁香3g,母丁香6g,刀豆6g,山楂10g,啤酒花6g,稻芽6g,薏米仁10g,藏菖蒲3g,党参6g,白术6g,枸杞子10g,山药15g,太子参12g,当归15g,女贞子10g,天冬10g,燕窝10g,银耳3g。
3.根据权利要求1或2所述的一种产后护理用中药,其特征在于:所述中药为散剂或丸剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510628992.7A CN105106916A (zh) | 2015-09-29 | 2015-09-29 | 一种产后护理用中药 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510628992.7A CN105106916A (zh) | 2015-09-29 | 2015-09-29 | 一种产后护理用中药 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105106916A true CN105106916A (zh) | 2015-12-02 |
Family
ID=54655185
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510628992.7A Pending CN105106916A (zh) | 2015-09-29 | 2015-09-29 | 一种产后护理用中药 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105106916A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105709077A (zh) * | 2016-03-20 | 2016-06-29 | 赵中美 | 一种治疗产后病的中药组合物及其制备方法 |
| CN105902805A (zh) * | 2016-06-27 | 2016-08-31 | 赵振莹 | 一种产后护理用中药 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040258778A1 (en) * | 2003-03-31 | 2004-12-23 | Farmar Jill B. | Lactation cessation and breast engorgement compositions and method of use |
| CN104524211A (zh) * | 2014-12-26 | 2015-04-22 | 王秀花 | 一种产后护理中药 |
-
2015
- 2015-09-29 CN CN201510628992.7A patent/CN105106916A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040258778A1 (en) * | 2003-03-31 | 2004-12-23 | Farmar Jill B. | Lactation cessation and breast engorgement compositions and method of use |
| CN104524211A (zh) * | 2014-12-26 | 2015-04-22 | 王秀花 | 一种产后护理中药 |
Non-Patent Citations (1)
| Title |
|---|
| 张理容: "生化汤在产后护理中的新思维", 《中国医药指南》 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105709077A (zh) * | 2016-03-20 | 2016-06-29 | 赵中美 | 一种治疗产后病的中药组合物及其制备方法 |
| CN105902805A (zh) * | 2016-06-27 | 2016-08-31 | 赵振莹 | 一种产后护理用中药 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102068707A (zh) | 一种b超使用的中药助影剂及其制备方法 | |
| CN104367879A (zh) | 一种用于治疗鸡劳伤的药物组合物及其制备方法 | |
| CN104288651A (zh) | 一种治疗产后缺乳的药物及其制备方法 | |
| CN104940740A (zh) | 一种治疗多囊卵巢综合征的中药组合物及其制备方法 | |
| CN103736072B (zh) | 一种治疗过敏性鼻炎的药物及其制备方法 | |
| CN103689559A (zh) | 一种有助于改善胃肠功能的养生保健食品配方及其制备方法 | |
| CN103989957A (zh) | 用于治疗胃阴亏虚型慢性胃炎的药物组合物及其制备方法 | |
| CN105106916A (zh) | 一种产后护理用中药 | |
| CN102293964B (zh) | 一种治疗胃溃疡的药物及其制备方法 | |
| CN105232987A (zh) | 一种促进神经外科术后康复的中药 | |
| CN104353051A (zh) | 一种治疗胃痛的中药制剂及其制备方法 | |
| CN101062335B (zh) | 一种祛黄褐斑的保健品 | |
| CN103860773A (zh) | 用于治疗心肌缺血的中药组合物及其制备方法 | |
| CN104042981A (zh) | 一种治疗产后便秘的药剂及制备方法 | |
| CN106474355A (zh) | 一种治疗心脏病的中药 | |
| CN104524479A (zh) | 一种治疗经前期综合征的中药组合物及其制备方法 | |
| CN104623374A (zh) | 一种治疗急性放射病的中药制剂及其制备方法 | |
| CN104353043A (zh) | 一种治疗五更泻的中药组合物及其制备方法 | |
| CN104784476A (zh) | 一种治疗心律不齐的中药胶囊及制备方法 | |
| CN107115410B (zh) | 一种中药泡浴配方、制备方法及使用方法 | |
| CN108721540A (zh) | 治疗肝癌六种情况的中药配方 | |
| CN104888091A (zh) | 一种治疗肠型急性放射病的中药组合物及其制备方法 | |
| CN105770760A (zh) | 主治胃溃疡的制剂及其制备方法 | |
| CN105943941A (zh) | 一种祛湿减肥中药组合物 | |
| CN105194433A (zh) | 一种内科治疗老年体虚症的中药组合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151202 |